CALCA and depressive symptom measurement: In a cross-sectional survey of migraine patients in the United States and Germany, Hubig et al. reported that 67% of participants exhibited severe interictal burden (MIBS-4 ≥5), with significant associations between MIBS-4 scores and depression, CGRP monoclonal antibody treatment, and HIT-6 scores [3,8].